האיגוד הישראלי לרפואת משפחה

הבדלים בין גרסאות בדף "המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת/ביבליוגרפיה למהדורת 2022"

מתוך ויקירפואה

שורה 277: שורה 277:
 
#Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine. 2011 Aug 4;365)5(.
 
#Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine. 2011 Aug 4;365)5(.
 
#U.S preventive Services task force. U.S preventive Services task force recommendation 2012.
 
#U.S preventive Services task force. U.S preventive Services task force recommendation 2012.
##Krumholz HM, Seeman TE, Merrill SS, Leon CFM, Vaccarino V, Silverman DI, et al. Lack of Association Between Cholesterol and Coronary Heart Disease Mortality and Morbidity and All-Cause Mortality in Persons Older Than 70 Years. JAMA: The Journal of the American Medical Association. 1994;272)17(.
+
#Krumholz HM, Seeman TE, Merrill SS, Leon CFM, Vaccarino V, Silverman DI, et al. Lack of Association Between Cholesterol and Coronary Heart Disease Mortality and Morbidity and All-Cause Mortality in Persons Older Than 70 Years. JAMA: The Journal of the American Medical Association. 1994;272)17(.
 
#Summary of current guidelines for the cancer-related checkup: recommendation. New York: American Cancer Society; 1988.
 
#Summary of current guidelines for the cancer-related checkup: recommendation. New York: American Cancer Society; 1988.
 
#Triezenberg DJ, Smith MA, Holmes TM. Cancer screening and detection in family practice: A MIRNET study. Journal of Family Practice. 1995;40)1(.
 
#Triezenberg DJ, Smith MA, Holmes TM. Cancer screening and detection in family practice: A MIRNET study. Journal of Family Practice. 1995;40)1(.

גרסה מ־06:28, 25 בנובמבר 2022

Preventative (1).png

המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת
מאת איגוד רופאי המשפחה בישראל, האגף למדיניות רפואית, ההסתדרות הרפואית בישראל

המלצות כוח המשימה הישראלי בנושא
קידום בריאות ורפואה מונעת
Ambox warning blue.png
ערך זה הוא הנחיה קלינית סגורה לעריכה
המלצות כוח המשימה.png
שם הפרק ביבליוגרפיה למהדורת 2022
עורך מדעי פרופסור אמנון להד, פרופ' חוה טבנקין, ד"ר תם אקסלרוד
מוציא לאור ההסתדרות הרפואית בישראל, האגף למדיניות רפואית, איגוד רופאי המשפחה בישראל
מועד הוצאה אוקטובר 2022
מספר עמודים 284
קישור באתר ההסתדרות הרפואית
Logo small.gif


  1. Wilson J, Junger G. The principles and practice of screening for disease. 1968.
  2. US Preventive Services Task Force. Grade Definitions After July 2012.
  3. Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, et al. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System. Circulation. 2016;133)14(.
  4. משרד הבריאות. תדריך לביצוע הערכות התפתחות לתינוקות ולפעוטות עד גיל 6 שנים. 12/2016
  5. United States Preventive Services Task Force. Guide to clinical Preventive Service. 2nd ed. Baltimore, MD: Williams & Wilkins ; 1996.
  6. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health care. Canada Communication group publishing ; 1998.
  7. Braveman P, Tarimo E. Screening in Primary Health Care:Setting Priorities With Limited Resources. WHO Publication ; 1994.
  8. משרד הבריאות. שינויים בשגרת החיסונים, 2003
  9. משרד הבריאות. הנחיות משרד הבריאות בנושא מעקב גדילה והתפתחות ילדים עד גיל 5 +עדכונים,
  10. ארגון רופאי הילדים. המלצות הוועדה המייעצת לארגון רופאי הילדים, 1992
  11. Valman HB. ABC of one to seven. Febrile convulsions. BMJ. 1993;306)6894(.
  12. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Medical Journal of Australia. 1989;150)11(.
  13. Temte JL. 2007 Childhood and adolescent immunization schedules: Evolution or intelligent design? Vol. 75, American Family Physician. 2007.
  14. משרד הבריאות. מתן חיסון פעיל נגד אבעבועות רוח. 11/2007
  15. משרד הבריאות. עדכון תדריך החיסונים של המחלקה לאפידמיולוגיה, 2007
  16. CDC. CDC Health Information for International Travel. 2008.
  17. Gahlinger PM. Motion sickness: How to help your patients avoid travel travail. Postgraduate Medicine. 1999;106)4(.
  18. אורקין י, אמיתי י, חונוביץ מ. בריאות התינוק והפעוט מידע שימושי לצוות טיפת חלב. דיונון, 2011
  19. משרד הבריאות. בדיקות סקר ביילודים לזיהוי מוקדם של מחלת תת-תריסיות, מחלת פנילקטונוריה ומחלות אחרות. 17/2009
  20. משרד הבריאות. ביצוע בדיקות דימות החושפות ילדים וילודים לקרינה מייננת. 18/2009
  21. משרד הבריאות. תדריך למניעת אנמיה וחוסר ברזל בתינוקות ובפעוטות. 17/2012
  22. ראש שירותי בריאות הציבור. שירות בריאות לתלמיד. 16/2012
  23. Beltran-Aguilar ED, Barker LK, Canto MT, Dye BA, Gooch BF, Griffin SO, et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveillance summaries : Morbidity and mortality weekly report Surveillance summaries / CDC. 2005;54)3(.
  24. Petersen PE. Global policy for improvement of oral health in the 21st century - Implications to oral health research of World Health Assembly 2007, World Health Organization. Vol. 37, Community Dentistry and Oral Epidemiology. 2009.
  25. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 01/2020
  26. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 16/2014
  27. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 08/2019
  28. קידום, הגנה ותמיכה בהנקה בטיפות חלב - חוזר משרד הבריאות - Promoting breastfeeding in family health centers
  29. Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. New England Journal of Medicine. 2016 May 5;374)18(.
  30. Meek JY, Noble L. Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics. 2022 Jul 1;150)1(.
  31. ההמלצות התזונתיות החדשות - משרד הבריאות
  32. מדריך לאנשי מקצוע להזנת התינוק והפעוט - חוזר משרד הבריאות - Infant and toddler feeding guide for healthcare professionals
  33. שינה בטוחה לתינוקות
  34. משרד הבריאות. הנחיות לשימוש בתכשירי פלואוריד. הנחיות בריאות השן מס' 3.2, 2021
  35. המחלות הנבדקות בבדיקות סקר ביילודים
  36. איתור אי יציבות מפרק הירך ביילודים ובתינוקות - חוזר משרד הבריאות - Screening for hip instability in neonates and infants
  37. עמותת גושן. פורטל בריאות ורווחת הילד בקהילה
  38. נוהל לאיתור נשים בסיכון לדיכאון בהיריון ולאחר לידה - חוזר משרד הבריאות
  39. Fixler DE, Laird WP. Validity of mass blood pressure screening in children. Pediatrics. 1983;72)4(.
  40. Zadik Z, Sthoeger D, Blachar Y. Blood pressure determinations in Israeli schoolchildren aged 5 to 14 years. Israel Journal of Medical Sciences. 1987;23)7(.
  41. Morais T, Bernier M, Turcotte F. Age- and sex-specific prevalence of scoliosis and the value of school screening programs. American Journal of Public Health. 1985;75)12(.
  42. US Preventive Services Task Force. Screening for Adolescent Idiopathic Scoliosis. JAMA. 1993;319)2(:165-72.
  43. Willers U, Svensson O, Hedlund R, Normelli H, Aaro S. Long-term results of boston brace treatment on vertebral rotation in idiopathic scoliosis. Spine )Phila Pa 1976(. 1993;18)4(.
  44. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. Journal of Urology. 1994;151)5(.
  45. מניעה וטיפול בהשמנה משרד הבריאות
  46. עידוד פעילות גופנית משרד הבריאות
  47. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית 01/2020
  48. Palti H. Blood pressure assessment in children. Isr J Med Sci. 1987;23)7(.
  49. Horan MJ, Falkner B, Kimm SYS. Report of the second task force on blood pressure control in children - 1987 - Task Force on Blood Pressure Control in Children. Pediatrics. 1987;79)1(.
  50. Baron AE, Freyer B, Fixler DE. Longitudinal blood pressures in blacks, whites, and mexican Americans during adolescence and early adulthood. American Journal of Epidemiology. 1986;123)5(.
  51. Weinstein SL, Dolan LA, Spratt KF, Peterson KK, Spoonamore MJ, Ponseti I v. Health and Function of Patients with Untreated Idiopathic Scoliosis: A 50-Year Natural History Study. J Am Med Assoc. 2003;289)5(.
  52. Berg AO. Screening for depression: Recommendations and rationale. Vol. 66, American Family Physician. 2002.
  53. Froom J, Schlager DS, Steneker S, Jaffe A. Detection of major depressive disorder in primary care patients. The Journal of the American Board of Family Practice / American Board of Family Practice. 1993;6)1(.
  54. פעילות גופנית וספורט בילדים ובבני נוער - נייר עמדה 2019
  55. US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Vol. 1. Rockville, MD: Agency for Healthcare Research and Quality (US); 2002.
  56. קנישקווי ב, אמיתי י, חונוביץ מ. בריאות התלמיד: מידע שימושי. ירושלים: משרד הבריאות 2003
  57. Berg AO. Screening for skin cancer: Recommendations and rationale. Vol. 65, American Family Physician. 2002.
  58. Lamberg L. "Epidemic“ of malignant melanoma: True increase or better detection? Vol. 287, Journal of the American Medical Association. 2002.
  59. Soldatos CR, Allaert FA, Ohta T, Dikeos DG. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Medicine. 2005;6)1(.
  60. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Archives of Internal Medicine. 2006;166)16(.
  61. Kahn-Greene ET, Killgore DB, Kamimori GH, Balkin TJ, Killgore WDS. The effects of sleep deprivation on symptoms of psychopathology in healthy adults. Sleep Medicine. 2007;8)3(.
  62. Alvarez GG, Ayas NT. The impact of daily sleep duration on health: a review of the literature. Vol. 19, Progress in cardiovascular nursing. 2004.
  63. Rains JC, Poceta JS. Headache and sleep disorders: Review and clinical implications for headache management. Vol. 46, Headache. 2006.
  64. Wolkove N, Elkholy O, Baltzan M, Palayew M. Sleep and aging: 1. Sleep disorders commonly found in older people. Vol. 176, CMAJ. 2007.
  65. Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Vol. 27, Pharmacotherapy. 2007.
  66. McGuire S. Institute of medicine. 2010. Strategies to reduce sodium intake in the united states. Washington, dc: The national academies press. Vol. 1, Advances in Nutrition. 2010.
  67. Sacks FM, Campos H. Dietary Therapy in Hypertension. New England Journal of Medicine. 2010;362)22(.
  68. Gidding SS, Lichtenstein AH, Faith MS, Karpyn A, Mennella JA, Popkin B, et al. Implementing american heart association pediatric and adult nutrition guidelines. Vol. 119, Circulation. 2009.
  69. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368)9548(.
  70. WCRF. Food, nutrition, physical activity and the prevention of cancer. The American Institute for Cancer Research )AICR(; World Cancer Research Fund )WCRF UK( World Cancer Research Fund International. 2007.
  71. Morrow JW, Keels MA, Hale KJ, Thomas HF, Davis MJ, Czerepak CS, et al. Preventive oral health intervention for pediatricians. Vol. 122, Pediatrics. 2008.
  72. Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutrition. 2004;7)1a(.
  73. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet. New England Journal of Medicine. 2008;359)3(.
  74. Widenhorn-Muller K, Hille K, Klenk J, Weiland U. Influence of having breakfast on cognitive performance and mood in 13-to 20-year-old high school students: Results of a crossover trial. Pediatrics. 2008;122)2(.
  75. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Washington DC; 2008.
  76. Meriwether RA, Lee JA, Lafleur AS, Wiseman P. Physical activity counseling. Vol. 77, American Family Physician. 2008.
  77. Marcus. Erratum: Physical activity intervention studies: What we know and what we need to know: A scientific statement from the American Heart Association Council on nutrition, physical activity, and metabolism )subcommittee on physical activity(; Council on cardiovascular disease in the young. Vol. 122, Circulation. 2010.
  78. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. Exercise training for type 2 diabetes mellitus: Impact on cardiovascular risk: A scientific statement from the american heart association. Circulation. 2009;119)25(.
  79. Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MSV. Physical activity and risk of ischemic stroke in the Northern Manhattan study. Neurology. 2009;73)21(.
  80. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet. 2009;374)9702(.
  81. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Vol. 41, Medicine and Science in Sports and Exercise. 2009.
  82. זלר ל, סוקניק ש. הקשר שבין עיסוק בספורט לבין התפתחות אוסטאוארתריטיס של הברכיים. הרפואה
  83. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA - Journal of the American Medical Association. 2008;300)9(.
  84. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010 Dec 1;33)12(.
  85. Hornsby W, Albright A. Diabetes. In: Durstine J, Moore G, editors. ACSM's Exercise Management for Persons with Chronic Diseases and Disabilities. 3rd ed. Williams & Wilkins; 2009. p. 182-91.
  86. Elsawy B, Higgins KE. Physical activity guidelines for older adults. American Family Physician. 2010;81)1(.
  87. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Medicine and Science in Sports and Exercise. 2011;43)7(.
  88. Lee DC, Sui X, Artero EG, Lee IM, Church TS, McAuley PA, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men the Aerobics Center Longitudinal Study. Circulation. 2011;124)23(.
  89. Haug C. The risks and benefits of HPV vaccination. Vol. 302, JAMA - Journal of the American Medical Association. 2009.
  90. Rothman SM, Rothman DJ. Marketing HPV vaccine: Implications for adolescent health and medical professionalism. Vol. 302, JAMA - Journal of the American Medical Association. 2009.
  91. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA - Journal of the American Medical Association. 2009;302)7(.
  92. Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology. 2012;13)1(.
  93. Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non¬vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology. 2012;13)1(.
  94. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia. New England Journal of Medicine. 2011;365)17(.
  95. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, et al. Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males. New England Journal of Medicine. 2011;364)5(.
  96. Read TRH, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus )HPV( vaccination programme. Sexually Transmitted Infections. 2011;87)7(.
  97. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet. 2011;377)9783(.
  98. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. New England Journal of Medicine. 2005 Jun 2;352)22(.
  99. Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews. 2011;
  100. USPSTF A-Z Topic Guide.
  101. Israel Center for Disease Control and MOH Department of Health Promotion and Education. INHIS and KAP surveys. 2003.
  102. איגוד רופאי הילדים. הנחיות והמלצות בנושא: רפואת מתבגרים. המפגש הרפואי עם בני נוער. ההסתדרות הרפואית בישראל, 2000
  103. טיפול בחומצה פולית למניעת מומים מולדים בתעלה העצבית - NTDs - neural tube defects - חוזר משרד הבריאות
  104. Sox HJ. Preventive Health Services in Adults. New England Journal of Medicine. 1994;330)22(.
  105. Implementing preventive services. Based on papers prepared for the International Symposium on Preventive Services in Primary Care: Issues and Strategies. L'Esterel, Quebec, Canada, October 4-7, 1987. Am J Prev Med. 1988;4)4 Suppl(.
  106. Braveman P, Tarimo E. Screening in primary health care: setting priorities with limited resources. 1994.
  107. Dobrossy L. Prevention in primary care: recommendations for promoting good practice. 1994.
  108. Patterson C, Chambers LW. Preventive health care. The Lancet. 1995 Jun;345)8965(.
  109. משרד הבריאות. הנחיות משרד הבריאות בנושא מעקב נשים בהיריון+עדכונים, 1995
  110. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of Prenatal Ultrasound Screening on Perinatal Outcome. New England Journal of Medicine. 1993;329)12(.
  111. Berkowitz RL. Should Every Pregnant Woman Undergo Ultrasonography? New England Journal of Medicine. 1993;329)12(.
  112. Bernaschek G, Stuempflen I, Deutinger J. The value of sonographic diagnosis of fetal malformations: Different results between indication-based and screening-based investigations. Prenatal Diagnosis. 1994;14)9(.
  113. Bragonier JR, Bemis-Heys RL. Cost-effectiveness in the provision of primary health care services for women. Primary Care Update for Ob/Gyns. 1994;1)6(.
  114. Roccella EJ. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure )JNC V(. Archives of Internal Medicine. 1993;153)2(.
  115. Pyorala K, Backer G de, Graham I, Poole-wilson P, Wood D. Prevention of coronary heart disease in clinical practice: Recommendations of the task force of the european society of cardiology, european atherosclerosis society and european society of hypertension. European Heart Journal. 1994;15)10(.
  116. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society consensus conference: 1. Introduction. Vol. 149, CMAJ. 1993.
  117. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. New England Journal of Medicine. 1995;333)20(.
  118. Summary of the Second Report of the National Cholesterol Education Program )NCEP( Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults )Adult Treatment Panel II(. JAMA: The Journal of the American Medical Association. 1993;269)23(.
  119. Willett WC. Diet and health: What should we eat? Science )1979(. 1994;264)5158(.
  120. Heaney RP. Optimal Calcium Intake. Vol. 274, JAMA: The Journal of the American Medical Association. 1995.
  121. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The Primary Prevention of Coronary Heart Disease in Women. New England Journal of Medicine. 1995 Jun 29;332)26(.
  122. Austoker J, Sanders D, Fowler G. Cancer Prevention in Primary Care: Smoking and cancer: Smoking cessation. BMJ. 1994;308)6942(.
  123. Austoker J. Melanoma: Prevention and early diagnosis. Vol. 308, British Medical Journal. 1994.
  124. Menczer J. The case against cytological mass screening for cervical cancer in Israel. Vol. 122, Harefuah. 1992.
  125. Blum A, Solberg E. The role of the family physician in ending the tobacco pandemic. Vol. 34, Journal of Family Practice. 1992.
  126. Kottke TE, Solberg LI, Brekke ML, Conn SA, Maxwell P, Brekke MJ. A controlled trial to integrate smoking cessation advice into primary care practice: Doctors helping smokers, round III. Journal of Family Practice. 1992;34)6(.
  127. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee )ACIP(. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 1991;40)RR-13(.
  128. Expanded Programme on Immunization : programme report for the year 1992, incorporating the recommendations of the Global Advisory Group, October 1992. 1993.
  129. Blaine Hollinger F. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. The American Journal of Medicine. 1989;87)3 SUPPL. 1(.
  130. Hall AJ. Hepatitis B vaccination: Protection for how long and against what? Vol. 307, British Medical Journal. 1993.
  131. Bar-Shany S, Avitzur M, Tur-Kaspa R. Antibodies to hepatitis C in Israeli blood donors: age, sex and ethnic differences from HBsAg positive carriers. In: First Joint Spanish-Israeli Meeting on Liver and Biliary Disease. Jerusalem; 1992.
  132. Green MS, Block C, Slater PE. Rise in the incidence of viral hepatitis in israel despite improved socioeconomic conditions. Reviews of Infectious Diseases. 1989;11)3(.
  133. Bogomolski-Yahalom V, Granot E, Linder N, Adler R, Korman S, Manny N, et al. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. Journal of Medical Virology. 1991;34)4(.
  134. Peckham CS. Issues underlying the evaluation of screening programmes. Vol. 54, British Medical Bulletin. 1998.
  135. Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine. 1992;10)SUPPL. 1(.
  136. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection Against Hepatitis A by an Inactivated Vaccine. JAMA: The Journal of the American Medical Association. 1994;271)17(.
  137. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatric Infectious Disease Journal. 1993;12)5(.
  138. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A Controlled Trial of a Formalin- Inactivated Hepatitis A Vaccine in Healthy Children. New England Journal of Medicine. 1992;327)7(.
  139. Bancroft WH. Hepatitis A Vaccine. New England Journal of Medicine. 1992 Aug 13;327)7(.
  140. Tormans G, van Damme P, van Doorslaer E. Cost-effectiveness analysis of hepatitis A prevention in travellers. Vaccine. 1992;10)SUPPL. 1(.
  141. van Damme P, Cramm M, van der Auwera JC, Meheus A. Hepatitis A vaccination for health care workers. BMJ. 1993 Jun 12;306)6892(.
  142. Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrrell H, Safary A, et al. Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. British Medical Journal. 1992;304)6837(.
  143. Behrens RH, Roberts JA. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ. 1994;309)6959(.
  144. Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Slepon R, et al. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. In: Israel Journal of Medical Sciences. 1994.
  145. Karetnyi Y v., Mendelson E, Shlyakhov E, Rubinstein E, Golubev N, Levin R, et al. Prevalence of antibodies against hepatitis A virus among new immigrants in Israel. Journal of Medical Virology. 1995;46)1(.
  146. Ministry of Health I. Hepatitis A in Israel - 1993. Monthly Epidemiological Record. 1993.
  147. Bader TF. Hepatitis A vaccine. Am J Gastroenterol. 1996 Feb;91)2(.
  148. Modan B, Shpilberg O, Anis E, Chetrit A, Luxenburg O, Rosenberg E, et al. The need for liver transplantation: a nationwide estimate based on consensus review. The Lancet. 1995;346)8976(.
  149. Ackerman Z, Ablin J, Shouval D. Active immunization against hepatitis A is now warranted in glucose-6- phosphate dehydrogenase-deficient subjects ]12[. Vol. 91, American Journal of Gastroenterology. 1996.
  150. Krause DS. Hepatitis A Vaccines. JAMA: The Journal of the American Medical Association. 1996 Aug 14;276)6(.
  151. Adler R, Shouval D. Hepatitis a prophylaxis vaccine or immunoglobulin? Clinical Immunotherapeutics. 1996;6)4(.
  152. Bower C, Stanley FJ. Issues in the prevention of spina bifida. Vol. 89, Journal of the Royal Society of Medicine. 1996.
  153. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. British Medical Journal )Clinical research ed(. 1981;282)6275(.
  154. Milunsky A, Jick H, Jick SS, Bruell CL, Maclaughlin DS, Rothman KJ, et al. Multivitamin/Folic Acid Supplementation in Early Pregnancy Reduces the Prevalence of Neural Tube Defects. JAMA: The Journal of the American Medical Association. 1989;262)20(.
  155. Swain RA, st. Clair L. The role of folic acid in deficiency states and prevention of disease. Vol. 44, Journal of Family Practice. 1997.
  156. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect. British Medical Journal. 1997;315)7112(.
  157. Phillips AN, Wannamethee SG, Walker M, Thomson A, Smith GD. Life expectancy in men who have never smoked and those who have smoked continuously: 15 year follow up of large cohort of middle aged British men. British Medical Journal. 1996;313)7062(.
  158. סלע ב. האם אנו מתקרבים לרגע האמת? הרפואה 131:524-30 ;1996
  159. Shaper AG, Wannamethee G, Walker M. Alcohol and coronary heart disease: A perspective from the British regional heart study. International Journal of Epidemiology. 1994;23)3(.
  160. McDonald P, Friedman EHI, Banks A, Anderson R, Carman V. Pneumococcal vaccine campaign based in general practice. British Medical Journal. 1997;314)7087(.
  161. מגמות בתחלואה ובתמותה מסרטן בישראל 1995-1970. המרכז הלאומי לבקרת מחלות .editor ,בראון-אפל א
  162. בריאות בישראל נתונים 3 :In .לוחות 6.13, 6.14 .editors ,אבורבה מ, עוזרי ר, גורדון ש, שטיין נ, מרציאנו א, חקלאי צ. .2001
  163. Wathen CN, MacMillan HL, Canadian Task Force on Preventive Health Care. Prevention of violence against women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ. 2003 Sep 16;169)6(.
  164. Rhodes K v., Levinson W. Interventions for Intimate Partner Violence Against Women: Clinical Applications. Vol. 289, Journal of the American Medical Association. 2003.
  165. Wathen CN, MacMillan HL. Interventions for Violence Against Women. JAMA. 2003 Feb 5;289)5(.
  166. Krug EG, Mercy JA, Dahlberg LL et. al. World report on violence and health - World Health Organization. The Lancet. 2002;360.
  167. אלימות בין בני זוג: עמדת ההסתדרות הרפואית בישראל והנחיות לרופאים בדבר זיהוי וטיפול. ההסתדרות הרפואית בישראל, 2003
  168. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung Cancer Screening With Helical Computed Tomography in Older Adult Smokers. JAMA. 2003 Jan 15;289)3(.
  169. Swensen SJ. Screening for cancer with computed tomography. BMJ. 2003 Apr 26;326)7395(.
  170. Jorenby D. Clinical Efficacy of Bupropion in the Management of Smoking Cessation. Drugs. 2002;62)Supplement 2(.
  171. Rigotti NA. Treatment of Tobacco Use and Dependence. New England Journal of Medicine. 2002 Feb 14;346)7(.
  172. www.nice.org.uk.
  173. National Institute for Clinical excellence )NICE(. Guidance on the use of nicotine replacement therapy )NRT( and bupropion for smoking cessation. Technology Appraisal Guidance . 2002;39.
  174. שטיינברג א, לוגר א, ממן ע, שטיינברג ש. השפעת העישון על מחלות אורתופדיות ותוצאות ניתוחים. הרפואה 2003;142)6(:442-5.
  175. Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. The Lancet. 2002 Oct;360)9339(.
  176. משרד הבריאות. דו״ח שר הבריאות על העישון בישראל 2003-2002
  177. Burns D, Garfinkel L, Samet J. Changes in cigarette-related disease risks and their implication for prevention and control. NIH Publication 974213. U.S. Department of Health and Human Services, Public Health Service. National Institutes of Health, National Cancer Institute; 1997.
  178. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics. 1999;36)6(.
  179. Burns D. Nicotine Addiction. In: Braunwald E, Hauser S, Fauci A, et al., editors. Harrison's Principles of Internal Medicine. 15th ed. McGraw Hill; 2001. p. 2574-7.
  180. Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000 Oct;45)10(.
  181. Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating Tobacco Use and Dependence. Chest. 2002 Mar;121)3(.
  182. Lieberman DA. Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals. JAMA. 2003 Dec 10;290)22(.
  183. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Vol. 143, Annals of Internal Medicine. 2005.
  184. Maciosek M v., Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities Among Effective Clinical Preventive Services. Results of a Systematic Review and Analysis. American Journal of Preventive Medicine. 2006;31)1(.
  185. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice )Constituted by representatives of nine societies and by invited experts(. European Heart Journal. 2007 May 4;28)19(.
  186. Barclay L, Vega C. Advantages and Disadvantages of Alcohol Intake on Cardiovascular Health Reviewed. Medscape.
  187. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM. Long-Term Follow-up of the West of Scotland Coronary Prevention Study. New England Journal of Medicine. 2007 Oct 11;357)15(.
  188. שירותי בריאות כללית המלצות קליניות לאבחון וטיפול בדיכאון בקהילה .טבנקין ח, מוניץ ח, גולדפרכט מ, פלד ע, 2006
  189. Knoops KTB, de Groot LCPGM, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. J Am Med Assoc. 2004;292)12(.
  190. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle. New England Journal of Medicine. 2000 Jul 6;343)1(.
  191. גופנית - מרשם לבריאות], משרד הבריאות, 2005
  192. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease. Circulation. 2003;107)24(.
  193. Pate RR. Physical Activity and Public Health-Reply. Vol. 274, JAMA: The Journal of the American Medical Association. 1995.
  194. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary Prevention of Ischemic Stroke. Stroke. 2006 Jun;37)6(.
  195. Saris WHM, Blair SN, van Baak MA, Eaton SB, Davies PSW, di Pietro L, et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st stock conference and consensus statement. Vol. 4, Obesity Reviews. 2003.
  196. Lee C do, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. American Journal of Clinical Nutrition. 1999;69)3(.
  197. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. Exercise and Hypertension. Medicine & Science in Sports & Exercise. 2004 Mar;36)3(.
  198. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: Clinical and public health advisory from the National High Blood Pressure Education Program. J Am Med Assoc. 2002;288)15(.
  199. Whelton SP, Chin A, Xin X, He J. Effect of Aerobic Exercise on Blood Pressure. Annals of Internal Medicine. 2002;136)7(.
  200. Lee IM. Physical Activity and Cancer Prevention - Data from Epidemiologic Studies. In: Medicine and Science in Sports and Exercise. 2003.
  201. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera E v., et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2012 Jan;62)1(.
  202. Strong WB, Malina RM, Blimkie CJR, Daniels SR, Dishman RK, Gutin B, et al. Evidence Based Physical Activity for School-age Youth. The Journal of Pediatrics. 2005 Jun;146)6(.
  203. Twisk JWR. Physical activity guidelines for children and adolescents a critical review. Vol. 31, Sports Medicine. 2001.
  204. Strength Training by Children and Adolescents. PEDIATRICS. 2001 Jun 1;107)6(.
  205. Epstein LH, Paluch RA, Kalakanis LE, Goldfield GS, Cerny FJ, Roemmich JN. How much activity do youth get? A quantitative review of heart-rate measured activity. Vol. 108, Pediatrics. 2001.
  206. Pivarnik JM, Chambliss HO, Clapp JF, Dugan SA, Hatch MC, Lovelady CA, et al. Impact of physical activity during pregnancy and postpartum on chronic disease risk. Vol. 38, Medicine and Science in Sports and Exercise. 2006.
  207. ACOG Committee Obstetric Practice. ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period. Obstet Gynecol. 2002;99)1(.
  208. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Archives of Neurology. 2001;58)3(.
  209. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women women who walk. Archives of Internal Medicine. 2001;161)14(.
  210. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Annals of Internal Medicine. 2006;144)2(.
  211. van Gelder BM, Tijhuis MAR, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D. Physical activity in relation to cognitive decline in elderly men: The FINE study. Neurology. 2004;63)12(.
  212. Epstein EF. Leisure activities and the risk of dementia in the elderly: Comment. Vol. 349, The New England Journal of Medicine. 2003.
  213. Weuve J, Kang JH, Manson JAE, Breteler MMB, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. J Am Med Assoc. 2004;292)12(.
  214. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurology. 2005;4)11(.
  215. Deary IJ, Whalley LJ, Batty GD, Starr JM. Physical fitness and lifetime cognitive change. Neurology. 2006;67)7(.
  216. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis. Archives of Physical Medicine and Rehabilitation. 2004;85)10(.
  217. Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: Systematic review and meta¬analyses. Vol. 334, British Medical Journal. 2007.
  218. Mazzeo RS, Tanaka H. Exercise prescription for the elderly: Current recommendations. Vol. 31, Sports Medicine. 2001.
  219. van Sluijs EMF, McMinn AM, Griffin SJ. Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials. BMJ. 2007 Oct 6;335)7622(.
  220. Young A, Dinan S. Activity in later life. BMJ. 2005 Jan 22;330)7484(.
  221. משרד החינוך. תכנית לימודים בחינוך גופני לכיתות ג-יב. ירושלים 2007
  222. תכנית לימודים בחינוך גופני לגיל הרך — לגן הילדים ולכיתות א-ב. ירושלים, 2007
  223. Knutson KL, Spiegel K, Penev P, van Cauter E. The metabolic consequences of sleep deprivation. Vol. 11, Sleep Medicine Reviews. 2007.
  224. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14)6(.
  225. National heart lung, and blood institute working group on insomnia. Insomnia: Assessment and Management in Primary Care. Am Fam Physician. 1999;59)11(:3029-38.
  226. van den Berg J, Neely G. Performance on a simple reaction time task while sleep deprived. Perceptual and Motor Skills. 2006;102)2(.
  227. Kendall AP, Kautz MA, Russo MB, Killgore WDS. Effects of sleep deprivation on lateral visual attention. International Journal of Neuroscience. 2006;116)10(.
  228. Killgore WDS, Balkin TJ, Wesensten NJ. Impaired decision making following 49 h of sleep deprivation. Journal of Sleep Research. 2006;15)1(.
  229. Rajaratnam SMW, Arendt J. Health in a 24-h society. Vol. 358, Lancet. 2001.
  230. Connor J, Norton R, Ameratunga S, Robinson E, Civil I, Dunn R, et al. Driver sleepiness and risk of serious injury to car occupants: Population based case control study. British Medical Journal. 2002;324)7346(.
  231. Belanger L, Morin CM, Langlois F, Ladouceur R. Insomnia and generalized anxiety disorder: Effects of cognitive behavior therapy for gad on insomnia symptoms. Journal of Anxiety Disorders. 2004;18)4(.
  232. Brasic JR. Screening people with disturbed sleep for depression. Perceptual and Motor Skills. 2006;103)3(.
  233. Ohayon MM, Lemoine P. Sleep and insomnia markers in the general population. Encephale. 2004;30)2(.
  234. Slemenda C, Brandt KD, Heilman DK, Mazzuca S, Braunstein EM, Katz BP, et al. Quadriceps weakness and osteoarthritis of the knee. Annals of Internal Medicine. 1997;127)2(.
  235. Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, et al. Meta-analysis: Chondroitin for osteoarthritis of the knee or hip. Vol. 146, Annals of Internal Medicine. 2007.
  236. Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: Network meta-analysis. BMJ )Online(. 2010;341)7775(.
  237. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: Findings from a national US sample. Annals of Family Medicine. 2010;8)1(.
  238. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Archives of Internal Medicine. 2009;169)6(.
  239. Lichtenberg D. ]Who is likely to gain from high dose supplementation of vitamin E?[. Harefuah. 2011;150)1(.
  240. אייזיקוביץ' צ, ויטנרשטיין ט, לבנשטיין א. סקר התעללות והזנחה של זקנים בישראל. אוניברסיטת חיפה, המרכז לחקר ולימוד הזיקנה, אש"ל וביטוח לאומי, 2004
  241. אלמגור-לוטן א. אלימות נגד נשים: ריכוז נתונים לשנת 2011. הוועדה לקידום מעמד האישה, הכנסת, 2011
  242. המועצה הלאומית לשלום הילד. פרקים 13 ו-14. In: לקט נתונים מתוך השנתון ילדים בישראל, 2011
  243. איתור זיהוי וטיפול בקטינים נפגעי התעללות והזנחה - חוזר משרד הבריאות
  244. איתור וטיפול נשים נפגעות אלימות במשפחה ע"י מטפלים - חוזר משרד הבריאות
  245. משרד הבריאות. מינוי ועדות קבועות לנושא אלימות במשפחה, ניצול מיני והזנחה של קטינים וחסרי ישע, 2003.
  246. משרד הבריאות. חובת יידוע. חוזר 01/2003
  247. משרד הבריאות. נוהל טיפול בנפגעי/עות תקיפה מינית, 2003
  248. העברת מידע בין מוסדות רפואיים לאיתור וזיהוי קטינים וחסרי ישע נפגעי אלימות במשפחה 1 - חוזר משרד הבריאות
  249. נוהל טיפול בזקנים נפגעי התעמרות - חוזר משרד הבריאות
  250. לוי ש. התעללות בקשישים והזנחת קשישים בישראל: נתונים ודרכי התמודדות. מרכז המידע של הכנסת, 2006
  251. ראביד ג. זה בידיים שלנו: ניתוח תחום מניעת אלימות נגד נשים, 2010
  252. שטינמץ ד, טבנקין ח. אלימות במשפחה: שכיחות התופעה בקרב מטופלים המבקרים במרפאתם הראשונית. הרפואה. 2008;147)12(:978-85.
  253. Campbell JC. Health consequences of intimate partner violence. Vol. 359, Lancet. 2002.
  254. Eisikovits Z, Winstok Z, Fishman G. The first Israeli national survey on domestic violence. Vol. 10, Violence Against Women. 2004.
  255. Feder G, Ramsay J, Dunne D, Rose M, Arsene C, Norman R, et al. How far does screening women for domestic )partner( violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK, National Screening Committee critieria. Vol. 13, Health Technology Assessment. 2009.
  256. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults. American Journal of Preventive Medicine. 1998 May;14)4(.
  257. Garcia-Moreno C, Watts C. Violence against women: An urgent public health priority. Vol. 89, Bulletin of the World Health Organization. 2011.
  258. Grynbaum M, Biderman A, Levy A, Petasne-Weinstock S. Domestic violence: Prevalence among women in a primary care center - A pilot study. Israel Medical Association Journal. 2001;3)12(.
  259. Screening for Family and Intimate Partner Violence: Recommendation Statement. Vol. 140, Annals of Internal Medicine. 2004.
  260. Nelson HD, Nygren P, McInerney Y, Klein J. Screening Women and Elderly Adults for Family and Intimate Partner Violence: A Review of the Evidence for the U.S. Preventive Services Task Force. Vol. 140, Annals of Internal Medicine. 2004.
  261. O'Campo P, Kirst M, Tsamis C, Chambers C, Ahmad F. Implementing successful intimate partner violence screening programs in health care settings: Evidence generated from a realist-informed systematic review. Social Science and Medicine. 2011;72)6(.
  262. Schein M, Biderman A, Baras M, Bennett L, Bisharat B, Borkan J, et al. The prevalence of a history of child sexual abuse among adults visiting family practitioners in Israel. Child Abuse and Neglect. 2000;24)5(.
  263. Taket A, Wathen CN, MacMillan H. Should health professionals screen all women for domestic violence? Vol. 1, PLoS Medicine. 2004.
  264. WHO - Expert meeting on Health-sector responses to violence against women. In Geneva; 2009.
  265. WHO Multi-country Study on Women's Health and Domestic Violence against Women. In 2005.
  266. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine. 2011 Aug 4;365)5(.
  267. U.S preventive Services task force. U.S preventive Services task force recommendation 2012.
  268. Krumholz HM, Seeman TE, Merrill SS, Leon CFM, Vaccarino V, Silverman DI, et al. Lack of Association Between Cholesterol and Coronary Heart Disease Mortality and Morbidity and All-Cause Mortality in Persons Older Than 70 Years. JAMA: The Journal of the American Medical Association. 1994;272)17(.
  269. Summary of current guidelines for the cancer-related checkup: recommendation. New York: American Cancer Society; 1988.
  270. Triezenberg DJ, Smith MA, Holmes TM. Cancer screening and detection in family practice: A MIRNET study. Journal of Family Practice. 1995;40)1(.
  271. Austoker J. Screening and self examination for breast cancer. Vol. 309, British Medical Journal. 1994.
  272. Jatoi I, Baum M. American and European recommendations for screening mammography in younger women: A cultural divide? Vol. 307, British Medical Journal. 1993.
  273. Shapiro S, Venet W, Strax P, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69)2(.
  274. Wright CJ, Mueller CB. Screening mammography and public health policy: the need for perspective. The Lancet. 1995;346)8966(.
  275. Austoker J. Cancer Prevention in Primary Care Screening for colorectal cancer. BMJ. 1994 Aug 6;309)6951(.
  276. Winawer SJ, St John DJ, Bond JH, Rozen P, Burt RW, Waye JD, et al. Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ. 1995;73)1(.
  277. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. New England Journal of Medicine. 1993;328)19(.
  278. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A Comparison of Fecal Occult-Blood Tests for Colorectal- Cancer Screening. New England Journal of Medicine. 1996;334)3(.
  279. Potshuma WFM, Westendorp RGJ, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: Is the evidence biased? BMJ. 1994;308)6939(.
  280. Grady D, Cummings SR, Petitti D, Rubin SM, Audet AM, Sox HC, et al. Guidelines for counseling postmenopausal women about preventive hormone therapy. Annals of Internal Medicine. 1992;117)12(.
  281. Wood AJJ, Belchetz PE. Hormonal Treatment of Postmenopausal Women. New England Journal of Medicine. 1994;330)15(.
  282. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Vol. 117, Annals of Internal Medicine. 1992.
  283. Wood AJJ, Riggs BL, Melton LJ. The Prevention and Treatment of Osteoporosis. New England Journal of Medicine. 1992 Aug 27;327)9(.
  284. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. New England Journal of Medicine. 1995;332)24(.
  285. רוזנפלד, קיצס-כהן, גולדשמיד. יתרונות וחסרונות הטיפול ההורמונלי התחליפי: עדכון. תרפיה שימושית, 1994
  286. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc. 1998;280)7(.
  287. Sidney S, Petitti DB, Quesenberry CP. Myocardial infarction and the use of estrogen and estrogen- progestogen in postmenopausal women. Annals of Internal Medicine. 1997;127)7(.
  288. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women. New England Journal of Medicine. 1997;337)23(.
  289. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, et al. Postmenopausal Hormone Therapy and Mortality. Obstetrical & Gynecological Survey. 1997;52)11(.
  290. Whitehead M. Treatments for menopausal and post-menopausal problems: Present and future. Bailliere's Clinical Obstetrics and Gynaecology. 1996;10)3(.

291. Barrett-Connor E. Fortnightly review: Hormone replacement therapy. BMJ. 1998;317)7156(. 292. Harris R. Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2002 Dec 3;137)11(. 293. Lu-Yao G. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002 Oct 5;325)7367(. 294. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, et al. A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer. New England Journal of Medicine. 2002 Sep 12;347)11(. 295. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The Influence of Finasteride on the Development of Prostate Cancer. New England Journal of Medicine. 2003 Jul 17;349)3(. 296. Frankel S, Smith GD, Donovan J, Neal D. Screening for prostate cancer. The Lancet. 2003 Mar;361)9363(. 297. Schroeder BM, American Cancer Society. ACS updates guideline for the early detection of cervical neoplasia and cancer. American Cancer Society. Am Fam Physician. 2003 May 1;67)9(. 298. Mahoney MC, Saslow D, Cohen CJ, ACS. ACS guideline for the early detection of cervical cancer. Am Fam Physician. 2003 Apr 15;67)8(. 299. U.S. Preventive Services Task Force. Screening for Cervical Cancer: Recommendations and Rationale. American Family Physician. 2003;67)8(:1759-66. .בורנשטיין י, אברמוביץ ח. חשיבות ביצוע סריקה המונית לגילוי מוקדם של סרטן צוואר הרחם במדינת ישראל. הרפואה .300 .176-80:)12(122;1992 סטרול ח, אליקים ר, הלפרן ז, ארבר נ. מניעה וגילוי מוקדם של סרטן הכרכשת בכלל האוכלוסיה: יום עיון וסיכום עמדת .301 .142:223-6;2003 .האיגוד לגסטרואנטרולוגיה. הרפואה 302. Walsh JME, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003 Mar 12;289)10(. 303. Sonnenberg A, Delco F Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002 Jan 28;162)2(. 304. Boyle P. Faecal occult blood testing )FOBT( as screening for colorectal cancer: the current controversy. Annals of Oncology. 2002 Jan;13)1(. 305. Detsky AS. Screening for Colon Cancer — Can We Afford Colonoscopy? New England Journal of Medicine. 2001 Aug 23;345)8(. 306. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002 Jun 6;346)23(. 307. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed Tomographic Virtual Colonoscopy to Screen for Colorectal Neoplasia in Asymptomatic Adults. New England Journal of Medicine. 2003 Dec 4;349)23(. 308. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002 Nov 7;347)19(. 309. Tall AR. Exercise to Reduce Cardiovascular Risk — How Much Is Enough? New England Journal of Medicine. 2002;347)19(. 310. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. J Am Med Assoc. 2003;289)2(. 311. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. New England Journal of Medicine. 2003;348)17(. .פוגלמן י. הנחיות קליניות בנושא מניעה וטיפול בהשמנת יתר. ההסתדרות הרפואית בישראל. 2003 .312 313. Estabrooks PA, Glasgow RE, Dzewaltowski DA. Physical Activity Promotion Through Primary Care. Vol. 289, Journal of the American Medical Association. 2003. 314. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Vol. 360, Lancet. 2002. 315. Chobanian A v., Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. Vol. 289, Journal of the American Medical Association. 2003. 316. Elley CR, Kerse N, Arroll B, Robinson E. Effectiveness of counselling patients on physical activity in general practice: Cluster randomised controlled trial. British Medical Journal. 2003;326)7393(. החוג לשיקום חולי לב והאיגוד הקרדיולוגי בישראל. מסמך עמדה בנושא פעילות גופנית במסגרת מניעתה הראשונית של .317 .מחלת הלב הכלילית. 2001 318. Hermansen K, Dinesen B, Hoie LH, Morgenstern E, Gruenwald J. Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: A literature review. Vol. 20, Advances in Therapy. 2003. 319. LaRosa JC. Understanding risk in hypercholesterolemia. Vol. 26, Clinical Cardiology. 2003.